Seer Market Share Analysis for November 2025

Explore Seer’s growing catalog of 36K+ multi-species proteins — definitively identified by our technology — to see how you can push the boundaries of your proteomics and genomics research. Search our catalog today.

Health > Biotechnology and Pharmaceuticals

Domainseer.bio

Year Founded2017

Employees51 - 200

Annual Revenue$15M - $25M

Seer

Seer (including company regionals)

seer.bio

See more website traffic and engagement information

Seer Revenue up to November 2025 is 15M - 25M

revenue generated by Seer top domains

Seer top domains revenue over 3 years

Revenue for Seer top domains

seer.bio15M - 25M

See more with Sales Intelligence

Total visits to Seer's top domains

Understand Seer market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

seer.bio15.6K

See more with Sales Intelligence

Avg. visit duration in Seer's top domains

Analyze Seer engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

seer.bio00:00:35

See more with Sales Intelligence

Avg. pageviews on Seer's top domains

See how Seer keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

seer.bio1.70

See more with Sales Intelligence

Seer top competitors by domain

Top similar sites in November 2025, ranked by their affinity

personalgenome.comCompany NamePersonal Genome DiagnosticsEmployees51 - 200HQUnited States, Maryland, BaltimoreAnnual revenue$15M - $25MTotal visits985Health > Biotechnology and Pharmaceuticals

Top technologies used by Seer

These are the website technologies, by industry, used by Seer top domains

Advertising (6)

Google Adsense

Audio Video Media (5)

YouTube

Content Management System (5)

WordPress

Widget (5)

Twemoji

More Technologies

11

See all

News & Signals from Seer

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRetinalGeniX Technologies, Inc. integrates with Seer, Inc..By integrating RetinalGenix's non-invasive retinal imaging platform with Seer Bio's advanced proteomic profiling, RetinalGenix aims to uncover molecular and cellular signatures associated with disease onset, progression, and risk - often before clinical symptoms appear.

NewsSeer, Inc. attends event US HUPO Conference.As a US HUPO Conference sponsor, Seer will host a seminar highlighting novel advances in scalable deep cellular proteomics using Seer's Proteograph(TM) Product Suite.

NewsSeer, Inc. attended event TD Cowen 45th Annual Healthcare Conference on Feb 21st '25.REDWOOD CITY, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) - Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming TD Cowen 45th Annual Healthcare Conference in Boston, MA.